Signature by Liberty Leaf Now Approved to Support Direct Billing to Veterans Affairs Canada via Medavie Blue Cross

Published: January 29, 2020

Signature by Liberty Leaf Now Approved to Support Direct Billing to Veterans Affairs Canada via Medavie Blue Cross

Signature By Liberty Leaf (“Signature”), a division of Liberty Leaf Holdings Ltd., has now approved to direct bill medical cannabis vaping devices for veterans and former RCMP officers, who qualify for up to $300 reimbursement from Veterans Affairs Canada (“VAC”), via Medavie Blue Cross.

The VAC reimbursement program is designed to alleviate some of the burdens experienced by Canadian veterans as a result of injuries or other afflictions they have suffered in the service of our country. Signature’s medical device product offerings include approved vaporizers and hardware, delivered direct to consumers.

Now that approved dry flower cannabis vaporizers qualify for reimbursement from VAC, Signature is able to assist veterans in receiving up to $300 reimbursement in purchases from its line of medical devices. Staff at Signature will complete all the necessary paperwork through Medavie Blue Cross and provide qualifying vaporizers to veterans, while making reimbursement applications. There is no need for veterans to pay out of pocket, other than for charges that don’t qualify under the program.

According to Ceri Willott, Special Projects Manager at Signature, “We at Signature are proud to facilitate and fulfil the medical devices our veterans require in order to help manage their conditions. We worked hard to make this reimbursement program happen.”

It is routinely acknowledged that medical cannabis can play a critical role in managing both physical pain, acute and chronic, as well as psychological distress for veterans. Medical cannabis has been ranked as a leading symptom relief resource for dealing with a number of psychological ailments including Post-Traumatic Stress Disorder (“PTSD”).

www.SignatureByLibertyLeaf.com is an e-commerce website that offers Canadians with curated cannabis accessories designed for the consuming public.

Recent News

View All News Items

Latest Article

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

Legalization 2.0: IP and Regulatory Considerations for Edibles, Extracts and Topicals

The legalization of cannabis edibles, extracts and topicals will expand the cannabis market and create new opportunities for producers, innovators and investors. According to a recent report from Deloitte, the Canadian market for these new cannabis products is expected to be worth $2.7 billion annually, with edibles accounting for more than half ($1.6 billion).

 

Read Article